查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1405814

促智藥市場規模、佔有率、趨勢分析報告：依型態、配銷通路、地區、細分市場預測，2023-2030

Nootropics Market Size, Share & Trends Analysis Report By Form (Capsules/ Tablets, Powder, Drinks), By Distribution Channel (Online, Offline), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10個工作天內

價格

促智藥市場成長與趨勢：

Grand View Research, Inc.的最新報告顯示，預計2030年全球促智藥市場規模將達到111.7億美元，2023年至2030年複合年成長率預計為14.6%。

全球市場在過去幾年中不斷成長，預計在預測期內將繼續成長。這一成長是由於消費者對促智藥對認知健康益處的認知不斷提高以及消費者改善心理表現的願望所推動的。隨著世界人口高齡化，人們對支持大腦健康的產品越來越感興趣，而促智藥被認為是可行的選擇。此外，壓力和心理健康問題的普遍存在也鼓勵人們探索認知增強劑。

促智膠囊很普及，因為它們易於服用，無需準備或混合。消費者只需用水吞服膠囊，這對生活忙碌的人來說是個方便的選擇。膠囊提供精確且穩定量的促智成分。對於認知增強劑而言，這一點尤其重要，因為正確的劑量對於實現預期效果至關重要。膠囊是藥物和營養補充的常見型態，可以提高促智食品的可信度。

由於消費者對這些產品的需求不斷成長，促智藥製造商越來越優先考慮天然成分。例如，2021年10月，促智慧量飲料品牌XITE推出促智純素蛋白棒，以吸引越來越多注重健康的消費者群。酒吧富含咖啡館、L-茶氨酸和睡茄等益智藥物，據說可以改善認知功能、注意力和能量水平。同樣，2019 年 4 月，Gaia Herbs 推出了新的純素補充品，名為 Bacopa（含過長沙）、Nootropic Focus（含藏紅花、檸檬香脂和留蘭香）以及 Agile Mind（含過長沙、銀杏和薑黃）。

促智藥市場報告亮點

  • 以型態，膠囊/錠劑促智藥細分市場在 2022 年佔據最大佔有率，達到 49.2%。膠囊和錠劑可以有效掩蓋許多促智藥的不良味道，使它們比粉狀補充品更容易吞嚥。此外，封裝和錠劑製程可防止成分暴露在空氣和濕氣中，從而延長成分的保存期限，從而降低污染風險。
  • 就配銷通路而言，預計2023年至2030年線上市場將以16.2%的複合年成長率成長。網路購物的便利性和普及性以及透過該管道提供的各種促智藥是推動分銷領域的主要因素。
  • 2022年，北美在全球市場中佔據超過41.2%的主要佔有率。這是由於北美人們健康意識的不斷增強以及對保持健康飲食和生活方式的興趣日益濃厚。該地區對健康和預防性醫療保健的關注正在推動對促智藥的需求。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章促智市場變數、趨勢和範圍

  • 市場體系展望
  • 產業價值鏈分析
    • 銷售/零售通路分析
    • 報酬率分析
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
    • 市場機會
    • 市場挑戰
  • 產業分析-波特五力分析
  • 打入市場策略

第4章消費行為分析

  • 人口趨勢分析
  • 消費者趨勢和偏好
  • 影響購買決策的因素
  • 消費品採用
  • 主要觀察結果和發現

第5章促智藥市場：型態估計與趨勢分析

  • 2022年和2030年型態變化分析和市場佔有率
  • 膠囊/錠劑
    • 2017-2030 年市場估計與預測
  • 粉末
    • 2017-2030 年市場估計與預測
  • 喝
    • 2017-2030 年市場估計與預測
  • 其他
    • 2017-2030 年市場估計與預測

第6章促智藥市場：配銷通路估計與趨勢分析

  • 2022年及2030年配銷通路波動分析及市場佔有率
  • 離線
    • 2017-2030 年市場估計與預測
  • 線上的
    • 2017-2030 年市場估計與預測

第7章促智藥市場：區域估計與趨勢分析

  • 2022年和2030年區域變化分析和市場佔有率
  • 北美洲
    • 2017-2030 年市場估計與預測
    • 按型態分類，2017-2030
    • 按配銷通路分類，2017-2030
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 2017-2030 年市場估計與預測
    • 按型態分類，2017-2030
    • 按配銷通路分類，2017-2030
    • 德國
    • 義大利
  • 亞太地區
    • 2017-2030 年市場估計與預測
    • 按型態分類，2017-2030
    • 按配銷通路分類，2017-2030
    • 中國
    • 印度
  • 中美洲和南美洲
    • 2017-2030 年市場估計與預測
    • 按型態分類，2017-2030
    • 按配銷通路分類，2017-2030
    • 巴西
  • 中東和非洲
    • 2017-2030 年市場估計與預測
    • 按型態分類，2017-2030
    • 按配銷通路分類，2017-2030
    • 阿拉伯聯合大公國

第8章競爭分析

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 參與企業概況
  • 財務績效
  • 產品基準評效
  • 2022年公司市場佔有率分析（%）
  • 企業熱力圖分析
  • 策略規劃
  • 本節分析的主要企業列表
    • Onnit Labs, Inc.
    • Reckitt Benckiser Group PLC
    • Mental Mojo, LLC
    • NooCube
    • Mind Lab Pro（Performance Lab Group Ltd）
    • TruBrain
    • Neu Mind, LLC
    • Nooflux LLC
    • Zhou Nutrition
    • Kimera Koffee
Product Code: GVR-4-68039-914-3

Nootropics Market Growth & Trends:

The global nootropics market size was estimated to reach USD 11.17 billion in 2030 and is expected to grow at a CAGR of 14.6% from 2023 to 2030, according to a new report by Grand View Research, Inc. The global market has witnessed increased growth in the last few years, which is expected to continue over the forecast period. This growth is driven by the increasing awareness among consumers regarding the cognitive health benefits of nootropics and their desire to improve mental performance. As the global population ages, there is a growing interest in products that support brain health, and nootropics are seen as a viable option. In addition, the prevalence of stress and mental health concerns is propelling individuals to explore cognitive enhancers.

Nootropic capsules have higher penetration as they are easy to take and do not require any preparation or mixing. Consumers can simply swallow a capsule with water, making it a convenient option for those with busy lifestyles. Capsules provide precise and consistent dosages of nootropic ingredients. This is particularly important when it comes to cognitive enhancers, as accurate dosing is crucial for achieving the desired effects. Capsules are a common form of pharmaceuticals and dietary supplements, which can enhance the perceived credibility of nootropic products.

Nootropics manufacturers are increasingly prioritizing natural ingredients in response to the growing consumer demand for such products. For instance, in October 2021, XITE, a nootropic energy drinks brand, launched a nootropic vegan protein bar to appeal to the growing consumer base of mind health-conscious consumers. The bars are packed with nootropics, such as caffeine, L-theanine, and ashwagandha, which are claimed to improve cognitive function, focus, and energy level. Similarly, in April 2019, Gaia Herbs launched new vegan supplements called Bacopa made using Bacopa; Nootropic Focus made with saffron, lemon balm, and spearmint; and Agile Mind made with Bacopa, gingko, and turmeric.

Nootropics Market Report Highlights:

  • Based on form, the capsule/ tablets nootropics segment held the largest share of 49.2% in 2022. Capsules and tablets effectively mask the unpleasant taste of many nootropics, making them easier to swallow compared to powdered supplements. In addition, the encapsulation or tableting process prolongs ingredients' shelf life by shielding them from exposure to air and moisture, reducing the risk of contamination
  • In terms of distribution channel, the online segment is anticipated to grow at a CAGR of 16.2% from 2023 to 2030. The convenience and popularity of online shopping and the availability of a wide variety of nootropics through this channel are key factors driving the distribution segment
  • North America held a major share of over 41.2% of the global market in 2022. This can be attributed to the rising trend of health consciousness among North Americans, leading to a heightened interest in maintaining a healthy diet and lifestyle. The region's focus on wellness and preventive healthcare drives the demand for nootropics

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Products & Third-Party Perspectives
    • 1.3.4. Primary Research
  • 1.4. Information Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Data Visualization
  • 1.6. Data Validation & Publishing

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Product Outlook
  • 2.3. Distribution Channel Outlook
  • 2.4. Regional Outlook

Chapter 3. Nootropics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Industry Value Chain Analysis
    • 3.2.1. Sales/Retail Channel Analysis
    • 3.2.2. Profit Margin Analysis
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
    • 3.3.3. Market Opportunities
    • 3.3.4. Market Challenges
  • 3.4. Industry Analysis - Porter's Five Forces Analysis
  • 3.5. Market Entry Strategies

Chapter 4. Consumer Behavior Analysis

  • 4.1. Demographics Analysis
  • 4.2. Consumer Trends and Preferences
  • 4.3. Factors Affecting Buying Decision
  • 4.4. Consumer Product Adoption
  • 4.5. Key Observations & Findings

Chapter 5. Nootropics Market: Form Estimates & Trend Analysis

  • 5.1. Form Movement Analysis & Market Share, 2022 & 2030
  • 5.2. Capsules/Tablets
    • 5.2.1. Market estimates and forecast, 2017 - 2030 (USD Million)
  • 5.3. Powder
    • 5.3.1. Market estimates and forecast, 2017 - 2030 (USD Million)
  • 5.4. Drinks
    • 5.4.1. Market estimates and forecast, 2017 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Market estimates and forecast, 2017 - 2030 (USD Million)

Chapter 6. Nootropics Market: Distribution Channel Range Estimates & Trend Analysis

  • 6.1. Distribution Channel Movement Analysis & Market Share, 2022 & 2030
  • 6.2. Offline
    • 6.2.1. Market estimates and forecast, 2017 - 2030 (USD Million)
  • 6.3. Online
    • 6.3.1. Market estimates and forecast, 2017 - 2030 (USD Million)

Chapter 7. Nootropics Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Movement Analysis & Market Share, 2022 & 2030
  • 7.2. North America
    • 7.2.1. Market estimates and forecast, 2017 - 2030 (USD Million)
    • 7.2.2. Market estimates and forecast, by form, 2017 - 2030 (USD Million)
    • 7.2.3. Market estimates and forecast, by distribution channel, 2017 - 2030 (USD Million)
    • 7.2.4. U.S.
      • 7.2.4.1. Market estimates and forecast, 2017 - 2030 (USD Million)
      • 7.2.4.2. Market estimates and forecast, by form, 2017 - 2030 (USD Million)
      • 7.2.4.3. Market estimates and forecast, by distribution channel, 2017 - 2030 (USD Million)
    • 7.2.5. Canada
      • 7.2.5.1. Market estimates and forecast, 2017 - 2030 (USD Million)
      • 7.2.5.2. Market estimates and forecast, by form, 2017 - 2030 (USD Million)
      • 7.2.5.3. Market estimates and forecast, by distribution channel, 2017 - 2030 (USD Million)
    • 7.2.6. Mexico
      • 7.2.6.1. Market estimates and forecast, 2017 - 2030 (USD Million)
      • 7.2.6.2. Market estimates and forecast, by form, 2017 - 2030 (USD Million)
      • 7.2.6.3. Market estimates and forecast, by distribution channel, 2017 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Market estimates and forecast, 2017 - 2030 (USD Million)
    • 7.3.2. Market estimates and forecast, by form, 2017 - 2030 (USD Million)
    • 7.3.3. Market estimates and forecast, by distribution channel, 2017 - 2030 (USD Million)
    • 7.3.4. Germany
      • 7.3.4.1. Market estimates and forecast, 2017 - 2030 (USD Million)
      • 7.3.4.2. Market estimates and forecast, by form, 2017 - 2030 (USD Million)
      • 7.3.4.3. Market estimates and forecast, by distribution channel, 2017 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Market estimates and forecast, 2017 - 2030 (USD Million)
      • 7.3.5.2. Market estimates and forecast, by form, 2017 - 2030 (USD Million)
      • 7.3.5.3. Market estimates and forecast, by distribution channel, 2017 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Market estimates and forecast, 2017 - 2030 (USD Million)
    • 7.4.2. Market estimates and forecast, by form, 2017 - 2030 (USD Million)
    • 7.4.3. Market estimates and forecast, by distribution channel, 2017 - 2030 (USD Million)
    • 7.4.4. China
      • 7.4.4.1. Market estimates and forecast, 2017 - 2030 (USD Million)
      • 7.4.4.2. Market estimates and forecast, by form, 2017 - 2030 (USD Million)
      • 7.4.4.3. Market estimates and forecast, by distribution channel, 2017 - 2030 (USD Million)
    • 7.4.5. India
      • 7.4.5.1. Market estimates and forecast, 2017 - 2030 (USD Million)
      • 7.4.5.2. Market estimates and forecast, by form, 2017 - 2030 (USD Million)
      • 7.4.5.3. Market estimates and forecast, by distribution channel, 2017 - 2030 (USD Million)
  • 7.5. Central & South America
    • 7.5.1. Market estimates and forecast, 2017 - 2030 (USD Million)
    • 7.5.2. Market estimates and forecast, by form, 2017 - 2030 (USD Million)
    • 7.5.3. Market estimates and forecast, by distribution channel, 2017 - 2030 (USD Million)
    • 7.5.4. Brazil
      • 7.5.4.1. Market estimates and forecast, 2017 - 2030 (USD Million)
      • 7.5.4.2. Market estimates and forecast, by form, 2017 - 2030 (USD Million)
      • 7.5.4.3. Market estimates and forecast, by distribution channel, 2017 - 2030 (USD Million)
  • 7.6. Middle East & Africa
    • 7.6.1. Market estimates and forecast, 2017 - 2030 (USD Million)
    • 7.6.2. Market estimates and forecast, by form, 2017 - 2030 (USD Million)
    • 7.6.3. Market estimates and forecast, by distribution channel, 2017 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. Market estimates and forecast, 2017 - 2030 (USD Million)
      • 7.6.4.2. Market estimates and forecast, by form, 2017 - 2030 (USD Million)
      • 7.6.4.3. Market estimates and forecast, by distribution channel, 2017 - 2030 (USD Million)

Chapter 8. Competitive Analysis

  • 8.1. Recent developments & impact analysis, by key market participants
  • 8.2. Company Categorization
  • 8.3. Participant's Overview
  • 8.4. Financial Performance
  • 8.5. Product Benchmarking
  • 8.6. Company Market Share Analysis, 2022 (%)
  • 8.7. Company Heat Map Analysis
  • 8.8. Strategy Mapping
  • 8.9. List of key companies analyzed in this section include:
    • 8.9.1. Onnit Labs, Inc. 
    • 8.9.2. Reckitt Benckiser Group PLC
    • 8.9.3. Mental Mojo, LLC
    • 8.9.4. NooCube
    • 8.9.5. Mind Lab Pro (Performance Lab Group Ltd)
    • 8.9.6. TruBrain
    • 8.9.7. Neu Mind, LLC
    • 8.9.8. Nooflux LLC
    • 8.9.9. Zhou Nutrition
    • 8.9.10. Kimera Koffee

List of Tables

  • Table 1 Nootropics market - Driving factor market analysis
  • Table 2 List of 14 nootropics that help enhance brain activity as well as performance
  • Table 3 Nootropics market- Restraint factor market analysis
  • Table 4 Nootropics market estimates & forecast, by form (USD Million)
  • Table 5 Nootropics market estimates & forecast, by distribution channel (USD Million)
  • Table 6 U.S. macro-economic outlay
  • Table 7 Canada macro-economic outlay
  • Table 8 Germany macro-economic outlay
  • Table 9 Italy macro-economic outlay
  • Table 10 China macro-economic outlay
  • Table 11 India macro-economic outlay
  • Table 12 Brazil macro-economic outlay
  • Table 13 South Africa macro-economic outlay
  • Table 14 Recent developments & impact analysis, by key market participants
  • Table 15 Company market share, 2022
  • Table 16 Company heat map analysis
  • Table 17 Key Companies launching new products
  • Table 18 Companies undergoing acquisitions
  • Table 19 Key Companies involved mergers and acquisitions  

List of Figures

  • Fig. 1 Nootropics market segmentation
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary research approaches
  • Fig. 5 Primary research process
  • Fig. 6 Market snapshot
  • Fig. 7 Form segment snapshot
  • Fig. 8 Distribution channel segment snapshot
  • Fig. 9 Competitive landscape Snapshot
  • Fig. 10 Global nootropics market size, 2017 to 2030 (USD Million)
  • Fig. 11 Global nootropics market - penetration & growth prospect mapping
  • Fig. 12 Nootropics market: Value chain analysis
  • Fig. 13 Nootropics market: Sales channel
  • Fig. 14 Nootropics market: Profit-margin analysis
  • Fig. 15 Nootropics market: Dynamics
  • Fig. 16 Global Nootropics Market Value; 2012, 2017 & 2022 (USD Million)
  • Fig. 17 Nootropics market: Porter's Five Forces analysis
  • Fig. 18 Roadmap of Nootropics Market
  • Fig. 19 Consumption nootropics. by age, 2022
  • Fig. 20 Consumption of supplements, by gender, 2022
  • Fig. 21 Spending on supplements, by income group, 2022
  • Fig. 22 Factors affecting buying decisions for nootropics
  • Fig. 23 Nootropics market, by form: Key takeaways
  • Fig. 24 Nootropics market, by form: Market share, 2022 & 2030
  • Fig. 25 Nootropics market estimates & forecasts, by capsules/ tablets, 2017 - 2030 (USD Million)
  • Fig. 26 Nootropics market estimates & forecasts, by powder, 2017 - 2030 (USD Million)
  • Fig. 27 Nootropics market estimates & forecasts, by drinks, 2017 - 2030 (USD Million)
  • Fig. 28 Nootropics market estimates & forecasts, by others, 2017 - 2030 (USD Million)
  • Fig. 29 Nootropics market, by distribution channel: Key takeaways
  • Fig. 30 Nootropics market, by distribution channel: Market share, 2022 & 2030
  • Fig. 31 Nootropics market estimates & forecasts through online channel, 2017 - 2030 (USD Million)
  • Fig. 32 Nootropics market estimates & forecasts through offline channel, 2017 - 2030 (USD Million)
  • Fig. 33 Nootropics market revenue, by region, 2022 & 2030, (USD Million)
  • Fig. 34 Regional marketplace: Key takeaways
  • Fig. 35 North America nootropics market estimates & forecast, 2017 - 2030 (USD Million)
  • Fig. 36 U.S. nootropics market estimates & forecast, 2017 - 2030 (USD Million)
  • Fig. 37 U.S. ADHD Insights, 2021
  • Fig. 38 Canada nootropics market estimates & forecast, 2017 - 2030 (USD Million)
  • Fig. 39 Europe nootropics market estimates & forecast, 2017 - 2030 (USD Million)
  • Fig. 40 Germany nootropics market estimates & forecast, 2017 - 2030 (USD Million)
  • Fig. 41 Italy nootropics market estimates & forecast, 2017 - 2030 (USD Million)
  • Fig. 42 Asia Pacific nootropics market estimates & forecast, 2017 - 2030 (USD Million)
  • Fig. 43 China nootropics market estimates & forecast, 2017 - 2030 (USD Million)
  • Fig. 44 India nootropics market estimates & forecast, 2017 - 2030 (USD Million)
  • Fig. 45 Central and South America nootropics market estimates & forecast, 2017 - 2030 (USD Million)
  • Fig. 46 Brazil nootropics market estimates & forecast, 2017 - 2030 (USD Million)
  • Fig. 47 Middle East & Africa nootropics market estimates & forecast, 2017 - 2030 (USD Million)
  • Fig. 48 UAE nootropics market estimates & forecast, 2017 - 2030 (USD Million)
  • Fig. 49 Company market share analysis, 2022
  • Fig. 50 Strategic framework of nootropics market